Stockreport

Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision [Yahoo! Finance]

Movano Inc.  (MOVE) 
PDF PLEASANTON, Calif. May 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced that it successfully submitted updated pivotal clinical trial results as well as p [Read more]